alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 112
Editorial Note: Nomenclature changes to part 112 appear at 81 FR 49896, July 29, 2016.

§ 112.60 Under this subpart, what requirements apply regarding records? ( a ) You must establish and keep records required under this subpart in accordance with the requirements of subpart O of this part.
( b ) For any biological soil amendment of animal origin you use, you must establish and keep the following records: ( 1 ) For a treated biological soil amendment of animal origin you receive from a third party, documentation (such as a Certificate of Conformance) at least annually that: ( i ) The process used to treat the biological soil amendment of animal origin is a scientifically valid process that has been carried out with appropriate process monitoring; and
( ii ) The biological soil amendment of animal origin has been handled, conveyed and stored in a manner and location to minimize the risk of contamination by an untreated or in process biological soil amendment of animal origin; and
( 2 ) For a treated biological soil amendment of animal origin you produce for your own covered farm(s), documentation that process controls (for example, time, temperature, and turnings) were achieved.
§ 1880.20 Does this part apply to me? This part and, through this part, pertinent portions of the OMB guidance in subparts A through I of 2 CFR part 180 (see table at 2 CFR 180.100(b)) apply to you if you are a— ( a ) Participant or principal in a “covered transaction” (see subpart B of 2 CFR part 180 and the definition of “nonprocurement transaction” at 2 CFR 180.970);
( b ) Respondent in a NASA suspension or debarment action;
( c ) NASA debarment or suspension official; or
( d ) NASA grants officer, agreements officer, or other official authorized to enter into any type of nonprocurement transaction that is a covered transaction.
§ 129.20 Plant construction and design. ( a ) The bottling room shall be separated from other plant operations or storage areas by tight walls, ceilings, and self-closing doors to protect against contamination. Conveyor openings shall not exceed the size required to permit passage of containers.
( b ) If processing operations are conducted in other than a sealed system under pressure, adequate protection shall be provided to preclude contamination of the water and the system.
( c ) Adequate ventilation shall be provided to minimize condensation in processing rooms, bottling rooms, and in container washing and sanitizing areas.
( d ) The washing and sanitizing of containers for bottled drinking water shall be performed in an enclosed room. The washing and sanitizing operation shall be positioned within the room so as to minimize any possible post-sanitizing contamination of the containers before they enter the bottling room.
( e ) Rooms in which product water is handled, processed, or held or in which containers, utensils, or equipment are washed or held shall not open directly into any room used for domestic household purposes.
H. Res. 849

In the House of Representatives, U.S., 

June 7, 2006.

Resolved, That at any time after the adoption of this resolution the Speaker may, pursuant to clause 2(b) of rule 

XVIII, declare the House resolved into the Committee of the 

Whole House on the state of the Union for consideration of 

the bill (H.R. 5521) making appropriations for the Legislative Branch for the fiscal year ending September 30, 2007, 

and for other purposes. The first reading of the bill shall be 

dispensed with. All points of order against consideration of 

the bill are waived. General debate shall be confined to the 

bill and shall not exceed one hour equally divided and controlled by the chairman and ranking minority member of the 

Committee on Appropriations. After general debate the bill 

shall be considered for amendment under the five-minute 

rule. The bill shall be considered as read. All points of order 

against provisions in the bill for failure to comply with clause 

2 of rule XXI are waived. Notwithstanding clause 11 of rule 

XVIII, no amendment to the bill shall be in order except 

those printed in the report of the Committee on Rules accom-
2

•HRES 849 EH 

panying this resolution. Each such amendment may be offered only in the order printed in the report, may be offered 

only by a Member designated in the report, shall be considered as read, shall be debatable for the time specified in the 

report equally divided and controlled by the proponent and an 

opponent, shall not be subject to amendment, and shall not 

be subject to a demand for division of the question in the 

House or in the Committee of the Whole. All points of order 

against such amendments are waived. At the conclusion of 

consideration of the bill for amendment the Committee shall 

rise and report the bill to the House with such amendments 

as may have been adopted. The previous question shall be 

considered as ordered on the bill and amendments thereto to 

final passage without intervening motion except one motion 

to recommit with or without instructions.

Attest: 

Clerk.
IB 

Union Calendar No. 116 

115TH CONGRESS 

1ST SESSION H. R. 951 

[Report No. 115–172] 

To extend the deadline for commencement of construction of a hydroelectric 

project. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 7, 2017 

Ms. FOXX introduced the following bill; which was referred to the Committee 

on Energy and Commerce 

JUNE 12, 2017 

Committed to the Committee of the Whole House on the State of the Union 

and ordered to be printed 


lotter on DSKBCFDHB2PROD with BILLS
2 

•HR 951 RH

A BILL 

To extend the deadline for commencement of construction 

of a hydroelectric project. 


lotter on DSKBCFDHB2PROD with BILLS
3 

•HR 951 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. EXTENSION. 

4 (a) IN GENERAL.—Notwithstanding the time period 

5 specified in section 13 of the Federal Power Act (16 

6 U.S.C. 806) that would otherwise apply to the Federal En7 ergy Regulatory Commission project numbered 12642, the 

8 Commission may, at the request of the licensee for the 

9 project, and after reasonable notice, in accordance with 

10 the good faith, due diligence, and public interest require11 ments of that section and the Commission’s procedures 

12 under that section, extend the time period during which 

13 the licensee is required to commence the construction of 

14 the project for up to 3 consecutive 2-year periods from 

15 the date of the expiration of the extension originally issued 

16 by the Commission. 

17 (b) REINSTATEMENT OF EXPIRED LICENSE.—If the 

18 period required for commencement of construction of the 

19 project described in subsection (a) has expired prior to the 

20 date of the enactment of this Act, the Commission may 

21 reinstate the license effective as of the date of its expira22 tion and the first extension authorized under subsection 

23 (a) shall take effect on the date of such expiration. 


lotter on DSKBCFDHB2PROD with BILLS
Union Calendar No. 116 

115TH CONGRESS 

1ST SESSION H. R. 951 

[Report No. 115–172] 

A BILL 

To extend the deadline for commencement of 

construction of a hydroelectric project. 

JUNE 12, 2017 

Committed to the Committee of the Whole House on the 

State of the Union and ordered to be printed 


lotter on DSKBCFDHB2PROD with BILLS
### Predicting Ground-Water Vulnerability to Nitrate in the Puget Sound Basin

By: M.L. ErwinA. J. Tesoriero

                            https://doi.org/10.3133/fs06197

#### Links

- More information:  **Publisher Index Page**                            (html)
-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report**                                                                                                     (pdf)                                                                                                                                     
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
###### Editorial Note on Part 112

#### Editorial Note:

Nomenclature changes to part 112 appear at 81 FR 49896, July 29, 2016.

#### § 112.179 When does a variance approved by FDA become effective?

A variance approved by FDA becomes effective on the date of our written decision on the petition.
#### In re FORRESTER.

(Supreme Court, Appellate Division, First Department.

December 24, 1914.)

In the matter of James Forrester.

No opinion. Referred to Hon. John J. Freedman, official referee. Settle order on notice.
#### § 960.3-1-4-1 Site identification as potentially acceptable.

The evidence for the identification of a potentially acceptable site shall be the types of information specified in appendix IV of this part. Such evidence will be relatively general and less detailed than that required for the nomination of a site as suitable for characterization. Because the gathering of detailed geologic data will not take place until after the recommendation of a site for characterization, the levels of information may be relatively greater for the evaluation of those guidelines in subparts C and D that pertain to surface-identifiable factors for such site. The sources of information shall include the literature in the public domain and the private sector, when available, and will be supplemented in some instances by surface investigations and conceptual engineering design studies conducted by the DOE. Geologic surface investigations may include the mapping of identifiable rock masses, fracture and joint characteristics, and fault zones. Other surface investigations will consider the aquatic and terrestrial ecology; water rights and uses; topography; potential offsite hazards; natural resource concentrations; national or State protected resources; existing transportation systems; meteorology and climatology; population densities, centers, and distributions; and general socioeconomic characteristics.
[Federal Register Volume 76, Number 2 (Tuesday, January 4, 2011)]
[Notices]
[Pages 335-336]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-33168]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Notice of Advisory Committee Meeting Date Change

AGENCY: Missile Defense Agency (MDA), DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: On Tuesday, December 28, 2010 (75 FR 81589) the Department of 
Defense announced meeting date changes to the closed meetings of the

[[Page 336]]

Missile Defense Advisory Committee. Due to administrative matters, 
these meetings have been rescheduled from January 6-7, 2011 to January 
19-20, 2011. There are no other changes to the notice announced on 
Tuesday, December 14, 2010 (75 FR 77848).

FOR FURTHER INFORMATION CONTACT: Mr. David Bagnati, Designated Federal 
Officer at <a href="/cdn-cgi/l/email-protection#e1aca5a0a2a18c8580cf8c888d"><span class="__cf_email__" data-cfemail="400d040103002d24216e2d292c">[email protected]</span></a>, phone/voice mail 703-695-6438, or mail at 7100 
Defense Pentagon, Washington, DC 20301-7100.

    Dated: December 29, 2010.
Morgan F. Park,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2010-33168 Filed 1-3-11; 8:45 am]
BILLING CODE 5001-06-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 99.2

                                  CERTIFICATION
                       PURSUANT TO 18 U.S.C. SECTION 1350,
           AS ADOPTED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         I, Stephen L. Brown,  as Chief  Executive  Officer of Franklin  Capital
Corporation (the "COMPANY") certify,  pursuant to 18 U.S.C. ss. 1350, as adopted
by Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

         (1) the  accompanying  Form 10-Q report for the period ending March 31,
2003 as filed with the U.S.  Securities and Exchange  Commission  (the "REPORT")
fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended; and

         (2) the  information  contained in the Report fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Dated:  May 14, 2003                                 /s/ HIRAM M. LAZAR
                                                     -------------------
                                                     Hiram M. Lazar
                                                     Chief Financial Officer



A signed  original of this  written  statement  required by Section 906 has been
provided  to  Franklin  Capital  Corporation  and will be  retained  by Franklin
Capital  Corporation and furnished to the Securities and Exchange  Commission or
its staff upon request.
#### § 600.205 Federal awarding agency review of risk posed by applicants.

Use of 2 CFR 200.205 (the DOS review of risk posed by applicants) is required for all selected competitive and non-competitive awards.
```

[108th Congress Public Law 272]
[From the U.S. Government Printing Office]

[DOCID: f:publ272.108]

[[Page 118 STAT. 818]]

Public Law 108-272
108th Congress

                            Joint Resolution

 
 Approving the renewal of import restrictions contained in the Burmese 
 Freedom and Democracy Act of 2003. <<NOTE: July 7, 2004 -  [H.J. Res. 
                                 97]>> 

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, <<NOTE: 50 USC 1701 
note.>> That Congress approves the renewal of the import restrictions 
contained in section 3(a)(1) of the Burmese Freedom and Democracy Act of 
2003.

    Approved July 7, 2004.

LEGISLATIVE HISTORY--H.J. Res. 97 (S.J. Res. 39):
---------------------------------------------------------------------------

SENATE REPORTS: No. 108-281 accompanying S.J. Res. 39 (Comm. on 
Finance).
CONGRESSIONAL RECORD, Vol. 150 (2004):
            June 14, considered and passed House.
            June 24, considered and passed Senate.

                                  <all>
```
Exhibit 10.2

                              TERMINATION AGREEMENT

         THIS TERMINATION AGREEMENT (the "Agreement") is made and entered into
effective as of June 02, 2006, by and among DCI USA, INC., a Delaware
corporation (the "Company") and CORNELL CAPITAL PARTNERS, LP, a Delaware limited
partnership (the "Investor").

                                    Recitals:

         WHEREAS, the Company and the Investor entered into a Standby Equity
Distribution Agreement (the "Standby Equity Distribution"); a Registration
Rights Agreement (the "Registration Rights Agreement"); an Escrow Agreement (the
"Escrow Agreement"); and the Company, the Investor, and Newbridge Securities
Corporation entered into a Placement Agent Agreement (the "Placement Agent
Agreement"), all of which are dated December 13, 2004 (collectively, the Standby
Equity Distribution Agreement, the Registration Rights Agreement, and the Escrow
Agreement, and the Placement Agent Agreement are referred to as the "Transaction
Documents.")

         NOW, THEREFORE, in consideration of the mutual promises, conditions and
covenants contained herein and in the Transaction Documents and other good and
valuable consideration, receipt of which is hereby acknowledged, the parties
hereto agree as follows:

         1.       Termination. The Company and the Investor hereby agree to
                  terminate the Transaction Documents and the respective rights
                  and obligations contained therein. As a result of this
                  provision, none of the parties shall have any rights or
                  obligations under or with respect to the Transaction
                  Documents.

         2.       Fees. The Investor has earned and shall retain all fees
                  received from the Company pursuant to Section 12.4 of the
                  Standby Equity Distribution Agreement including the 200,000
                  shares of Series A Preferred Stock.


                  [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

<PAGE>

         IN WITNESS WHEREOF, the parties have signed and delivered this
Termination Agreement on the date first set forth above.

DCI USA, INC.                                CORNELL CAPITAL PARTNERS, LP

By: /s/ Jonathan I. Ofir                     By: Yorkville Advisors, LLC
    --------------------------
Name:    Jonathan I Ofir                     Its: General Partner
Title:   C.E.O.
                                             By: /s/ Mark A. Angelo
                                                 ------------------------------
                                             Name:    Mark A. Angelo
                                             Title:   Portfolio Manager
§ 1271.37 Will establishment registrations and HCT/P listings be available for inspection, and how do I request information on registrations and listings? ( a ) Any registration on Form FDA 3356 filed in paper or electronic format by each establishment will be available for public inspection through the Center for Biologics Evaluation and Research Human Cell and Tissue Establishment Registration—Public Query Web site by using the CBER electronic Web-based application or by going in person to the Food and Drug Administration, Dockets Management Staff Public Reading Room (see address in § 20.120(a) of this chapter). The following information submitted under the HCT/P requirements is illustrative of the type of information that will be available for public disclosure when it is compiled: ( 1 ) A list of all HCT/P's;
( 2 ) A list of all HCT/P's manufactured by each establishment;
( 3 ) A list of all HCT/P's discontinued; and
( 4 ) All data or information that has already become a matter of public record.
( b ) You should direct your other requests for information regarding HCT/P establishment registrations and HCT/P listings to the Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Communication, Outreach and Development, 10903 New Hampshire Ave., Bldg. 71, Rm. 3103, Silver Spring, MD 20993-0002.
[80 FR 18094, Apr. 3, 2015, as amended at 88 FR 45067, July 14, 2023]
EXHIBIT 23.1
**INDEPENDENT AUDITORS' CONSENT**
We consent to the incorporation by reference in RegistrationStatement Nos. 333-57441, 333-39898, 333-46140, 333-46144, 333-73884 on Form S-8and No. 333-81276 on Form S-3/A of Com21, Inc. and its subsidiaries of ourreports dated January 16, 2002 (March 29, 2002 as to Note 7) appearing in thisAnnual Report on Form 10-K of Com21, Inc. for the year ended December 31, 2001.

 
**Deloitte & Touche LLPSan Jose, CaliforniaMarch 29, 2002**
IV 

115TH CONGRESS 

1ST SESSION H. RES. 46 

Recognizing the increased risk of sleep apnea among soldiers returning from 

active duty and the benefits of continuous positive airway pressure 

(CPAP) therapy on treating obstructive sleep apnea (OSA) in soldiers 

suffering from Posttraumatic Stress Disorder (PTSD). 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 12, 2017 

Mr. GRAVES of Missouri (for himself and Mr. WALZ) submitted the following 

resolution; which was referred to the Committee on Armed Services, and 

in addition to the Committee on Veterans’ Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of 

such provisions as fall within the jurisdiction of the committee concerned 

RESOLUTION 

Recognizing the increased risk of sleep apnea among soldiers 

returning from active duty and the benefits of continuous 

positive airway pressure (CPAP) therapy on treating obstructive sleep apnea (OSA) in soldiers suffering from 

Posttraumatic Stress Disorder (PTSD). 

Whereas 12,000,000 to 18,000,000 people in the United 

States remain untreated for (OSA); 

Whereas untreated OSA can lead to heart disease, stroke, hypertension, type 2 diabetes, and depression; 


rfrederick on DSKBCBPHB2PROD with BILLS
2 

•HRES 46 IH 

Whereas 54 percent of the patients with PTSD who underwent sleep studies at Walter Reed National Military Medical Center were diagnosed with OSA; 

Whereas 20 percent of soldiers will develop sleep apnea in 

their lifetime; 

Whereas soldiers are 4 times more likely to develop sleep 

apnea than non-veteran civilians; 

Whereas studies show that 37 percent of soldiers showing 

symptoms for PTSD also report symptoms of insufficient 

sleep; 

Whereas veterans suffering from PTSD experience fewer 

nightmares when their OSA is treated with continuous 

positive airway pressure (CPAP) therapy; and 

Whereas the lack of public awareness of the disease, poor 

sleep habits during active duty, and the effects of PTSD 

among veterans that lead to poor sleep leads to many 

undiagnosed, untreated, and severe cases: Now, therefore, 

be it 

1 Resolved, That the House of Representatives— 

2 (1) supports raising public awareness of sleep 

3 apnea, especially for United States soldiers and vet4 erans; 

5 (2) supports providing access to care for sol6 diers and veterans with sleep illnesses such as ob7 structive sleep apnea (OSA); 

8 (3) encourages all United States soldiers and 

9 veterans to seek and maintain healthy sleep habits 

10 both during and after active duty; and 


rfrederick on DSKBCBPHB2PROD with BILLS
3 

•HRES 46 IH 

1 (4) further explores continuous positive airway 

2 pressure (CPAP) as a viable treatment for OSA in 

3 patients with Posttraumatic Stress Disorder 

4 (PTSD). 

Æ 


rfrederick on DSKBCBPHB2PROD with BILLS